ARTICLE | Clinical News
Lu AA24493: Phase I started
October 22, 2007 7:00 AM UTC
LUN began a Phase I trial in patients. The company licensed rights to Lu AA24493 for indications related to the central nervous system from Warren under a 2002 agreement (see BioCentury, Feb. 25, 2002...